NCT04376229

Brief Summary

The Johns Hopkins Proton Therapy center is establishing a registry to capture the full 3D radiation dosimetry delivered to the patient, baseline clinical data, and disease, toxicity and quality of life outcomes. The goal is to have all patients treated at the proton center to be included in the registry to enable future comparisons of treatment outcomes to assist in understanding which patients can benefit from the use of protons.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
177mo left

Started Apr 2020

Longer than P75 for all trials

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Apr 2020Dec 2040

Study Start

First participant enrolled

April 7, 2020

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

April 30, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 6, 2020

Completed
10.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2030

Expected
10 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2040

Last Updated

July 1, 2025

Status Verified

June 1, 2025

Enrollment Period

10.7 years

First QC Date

April 30, 2020

Last Update Submit

June 30, 2025

Conditions

Keywords

proton therapy

Outcome Measures

Primary Outcomes (1)

  • Research registry of cancer patients receiving proton radiation therapy

    This is a clinic based registry of cancer patients' data from participants to be collected over 15 years. The registry will be populated with 3D anatomy and radiation dosimetry from the RayStation treatment planning system used to plan all proton therapy patients. Clinical data will be extracted electronically from the MOSAIQ oncology information system used to manage the radiation therapy treatments. Structured clinical assessments will be routinely captured in the clinical workflow during patient encounters. Patient reported outcomes will be captured with iPad's using the OncoBrowser tools developed in radiotherapy that also interface with MOSAIQ.

    15 years

Study Arms (1)

Cancer patients receiving proton radiation therapy

Registry of cancer patients who receive proton radiation therapy to track disease and toxicity outcomes.

Other: Registry

Interventions

Registry of cancer patients who receive proton radiation therapy

Cancer patients receiving proton radiation therapy

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

cancer patients with proton therapy

You may qualify if:

  • All patients treated at the proton center.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Sibley Memorial Hospital

Washington D.C., District of Columbia, 20016, United States

RECRUITING

Suburban Hospital

Washington D.C., District of Columbia, 20814, United States

RECRUITING

Bayview Hospital

Baltimore, Maryland, 21224, United States

RECRUITING

Johns Hopkins Hospital

Baltimore, Maryland, 21287, United States

RECRUITING

MeSH Terms

Conditions

Neoplasms, Second Primary

Interventions

Registries

Condition Hierarchy (Ancestors)

Neoplasms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesRecordsOrganization and AdministrationHealth Services AdministrationHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Curtiland Deville, MD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Akila Viswanathan, MD

CONTACT

Dana Kaplin, MPH

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
15 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 30, 2020

First Posted

May 6, 2020

Study Start

April 7, 2020

Primary Completion (Estimated)

December 1, 2030

Study Completion (Estimated)

December 1, 2040

Last Updated

July 1, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations